Ignite Creation Date:
2025-12-24 @ 11:50 PM
Ignite Modification Date:
2026-02-23 @ 3:01 PM
Study NCT ID:
NCT03745651
Status:
COMPLETED
Last Update Posted:
2023-09-28
First Post:
2018-11-15
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
TRuE AD2 - An Efficacy and Safety Study of Ruxolitinib Cream in Adolescents and Adults With Atopic Dermatitis
Sponsor:
Incyte Corporation
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-12-20
Start Date Type:
ACTUAL
Primary Completion Date:
2019-11-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-11-09
Completion Date Type:
ACTUAL
First Submit Date:
2018-11-15
First Submit QC Date:
None
Study First Post Date:
2018-11-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-10-20
Results First Submit QC Date:
None
Results First Post Date:
2021-12-17
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2020-11-19
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2023-09-21
Last Update Post Date:
2023-09-28
Last Update Post Date Type:
ACTUAL